Interius

is a Pennsylvania-based biotechnology company that researches and develops in vivo cell and gene therapies for the treatment of cancer and autoimmune diseases...
Read more
Interius President & CEO: Philip R. Johnson

President & CEO

Philip R. Johnson

CEO Approval Rating

90/100

2019

PrivateIndependent Company

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$217.5M

Interius Competitors

1Arcellx
2Jubilant Therapeutics
3Athos Therapeutics
4Kite Pharma
5Regenxbio
6Autolus

Trending Companies